M. Larsen

Molecular and Cellular Therapies · 2016

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Whom M. Larsen trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Felix Kratz

Papers from M. Larsen's perspective

Ordered by how strongly the researchers M. Larsen trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The Major Histocompatibility Complex–related Fc Receptor for IgG (FcRn) Binds Albumin and Prolongs Its Lifespan (Journal of Experimental Medicine)
  2. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. (Journal of Controlled Release)
  3. FcRn: the neonatal Fc receptor comes of age
  4. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. (Clinical Cancer Research)
  5. Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. (Biological and Pharmaceutical Bulletin)
  6. Unraveling the mysteries of serum albumin—more than just a serum protein (Frontiers in Physiology)
  7. Impact of albumin on drug delivery--new applications on the horizon. (Journal of Controlled Release)
  8. Albumin: Biochemical properties and therapeutic potential (Hepatology)
  9. Crystal Structure Analysis of Warfarin Binding to Human Serum Albumin (Journal of Biological Chemistry)
  10. Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines (Journal of drug targeting (Print))

Their papers